AlloDirect, Inc

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

AlloDirect, Inc - overview

Established

2025

Location

Valparaiso, Indiana, US

Primary Industry

Software

About

Based in the US, AlloDirect, Inc, operates as a direct-sourcing platform for human tissue and biologics, connecting accredited tissue banks with healthcare facilities. Based in Valparaiso, the US and founded in 2025, AlloDirect, Inc provides a platform that connects AATB-accredited tissue banks with healthcare facilities. In September 2026, AlloDirect, Inc raised USD 0. 9 mn in pre-seed funding from unspecified investors, marking its first funding round.


AlloDirect offers a direct sourcing platform for human tissue, connecting surgery centers, hospitals, and other care sites that utilize grafts directly to AATB-accredited tissue banks. The platform allows users to search for and order tissue grafts while ensuring compliance with regulatory documentation requirements, streamlining the procurement process and maintaining transparency through documented transactions. AlloDirect serves healthcare institutions engaged in orthopedic, spine, sports medicine, and wound care, facilitating access to a comprehensive range of tissue types across the US. AlloDirect generates revenue through a fee structure associated with direct orders placed by its clients, including surgery centers and hospitals.


The B2B model allows clients to place orders on their purchase orders, receiving a consolidated invoice regardless of the number of tissue banks they source from. The pricing reflects the tissue bank's established fees, ensuring no additional distributor margins inflate costs for end users. Each order includes necessary documentation, enhancing compliance and audit processes, while the absence of minimum order quantities promotes broader usage across healthcare sectors. The company plans to expand its network of tissue banks and enhance its platform capabilities to improve user experience and accessibility.


Current initiatives include developing additional features to streamline the ordering process and increase the range of available tissue types.


Primary Industry

Software

Sub Industries

Software, Medical Software

Website

allo.direct

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

AlloDirect, Inc - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Unspecified RoundCompletedAlloDirect, Inc-

Displaying 1 - 1 of 1

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.